AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34897869 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 44
Study 33148768 — intervention group
Group type: EXPERIMENTAL
Intervention: Atopic dermatitis (by UK criteria)
Number of subjects: 7275
Study 33148768 — intervention group
Group type: EXPERIMENTAL
Intervention: Atopic dermatitis (by ISAAC)
Number of subjects: 7275
Study 33148768 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma
Number of subjects: 7275
Study 33148768 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhinitis
Number of subjects: 7275
Study 33148768 — intervention group
Group type: COMPARATOR
Intervention: Atopic dermatitis (severe disease)
Number of subjects: 7275
Study 33148768 — intervention group
Group type: COMPARATOR
Intervention: Asthma (severe disease)
Number of subjects: 7275
Study 33148768 — intervention group
Group type: COMPARATOR
Intervention: Rhinitis (severe disease)
Number of subjects: 7275
Study 33148768 — intervention group
Group type: COMPARATOR
Intervention: Asthma (highest quintile wealth score)
Number of subjects: 7275
Study 33148768 — intervention group
Group type: COMPARATOR
Intervention: Rhinitis (highest quintile wealth score)
Number of subjects: 7275
Study 33148768 — intervention group
Group type: EXPERIMENTAL
Intervention: Having atopic dermatitis (ISAAC)
Number of subjects: 7275
Study 33148768 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma and rhinitis association
Number of subjects: 7275
Study 34175192 — intervention group
Group type: EXPERIMENTAL
Intervention: Active deep rTMS targeting the posterior superior insula (PSI)
Number of subjects: 31
Study 34175192 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 31
Study 35502600 — intervention group
Group type: EXPERIMENTAL
Intervention: ravulizumab
Number of subjects: 441
Study 34919219 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (oral) after surgery for at least 1 week
Number of subjects: 49
Study 34919219 — intervention group
Group type: COMPARATOR
Intervention: Control group (no atorvastatin postoperatively)
Number of subjects: 49
Study 35833967 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot water immersion in fresh water (FWB)
Number of subjects: 13
Study 35833967 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot water immersion in salt water (SWB; 5.0%wt/vol Epsom salt)
Number of subjects: 13
Study 35833967 — intervention group
Group type: COMPARATOR
Intervention: Both FWB and SWB
Number of subjects: 13
Study 35833967 — intervention group
Group type: COMPARATOR
Intervention: RWL followed by recovery process
Number of subjects: 13
Study 34216729 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-detected osteophytes in participants with bone marrow lesions (BMLs)
Number of subjects: 334
Study 34216729 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-detected osteophytes in participants with effusion-synovitis
Number of subjects: 334
Study 34216729 — intervention group
Group type: COMPARATOR
Intervention: MRI-detected osteophytes in participants without baseline BMLs or effusion-synovitis
Number of subjects: 334
Study 35442430 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic 270° posterior partial fundoplication (PF)
Number of subjects: 456
Study 35442430 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic 360° total fundoplication (TF)
Number of subjects: 456
Study 35442430 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PF and TF
Number of subjects: 456
Study 34477217 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional recruitment methods (physician referral, newspaper and radio advertisements, letterbox drops, posters/flyers, word‐of‐mouth)
Number of subjects: 100
Study 34477217 — intervention group
Group type: EXPERIMENTAL
Intervention: Modern recruitment methods (patient recruitment services, social media, Google advertisements, websites, email)
Number of subjects: 100
Study 34477217 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of traditional and modern recruitment methods
Number of subjects: 100
Study 34477217 — intervention group
Group type: COMPARATOR
Intervention: Traditional and modern recruitment methods
Number of subjects: 100
Study 32580480 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle Energy Technique (MET)
Number of subjects: 60
Study 32580480 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrust Technique
Number of subjects: 60
Study 32580480 — intervention group
Group type: COMPARATOR
Intervention: Simulated Technique (Control)
Number of subjects: 60
Study 34106317 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymorphone (1.8, 3.2, 5.6, 10, 18, 32 mg/70 kg)
Number of subjects: 6
Study 34106317 — intervention group
Group type: COMPARATOR
Intervention: Hydromorphone (1.8, 3.2, 5.6, 10, 18 mg/70 kg)
Number of subjects: 6
Study 34106317 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone (18, 32, 56 mg/70 kg)
Number of subjects: 6
Study 34106317 — intervention group
Group type: COMPARATOR
Intervention: Morphine (18, 32 mg/70 kg)
Number of subjects: 6
Study 34106317 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 32025883 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone application
Number of subjects: 105
Study 32025883 — intervention group
Group type: COMPARATOR
Intervention: 2% chlorhexidine digluconate (CHX)
Number of subjects: 105
Study 32025883 — intervention group
Group type: COMPARATOR
Intervention: Conventional stepwise excavation with no disinfectants (Control)
Number of subjects: 105
Study 35545122 — intervention group
Group type: EXPERIMENTAL
Intervention: CADe-assisted colonoscopy
Number of subjects: 800
Study 35545122 — intervention group
Group type: COMPARATOR
Intervention: HDWL colonoscopy alone
Number of subjects: 800
Study 33706305 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5% ammonium fluoride varnish (Fluor Protector S)
Number of subjects: 180
Study 33706305 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% NaF varnish (Duraphat)
Number of subjects: 180
Study 33706305 — intervention group
Group type: COMPARATOR
Intervention: Professional tooth-cleaning (control group)
Number of subjects: 180
Study 32383277 — intervention group
Group type: EXPERIMENTAL
Intervention: Assay-guided treatment (AGT; N=151)
Number of subjects: 304
Study 32383277 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU; N=153)
Number of subjects: 304
Study 33871246 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoinertial resistance training
Number of subjects: 35
Study 33871246 — intervention group
Group type: EXPERIMENTAL
Intervention: Free-weight resistance training
Number of subjects: 35
Study 33871246 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study 32081489 — intervention group
Group type: EXPERIMENTAL
Intervention: Proxima A (bilateral GA)
Number of subjects: 495
Study 32081489 — intervention group
Group type: EXPERIMENTAL
Intervention: Proxima B (fellow eye CNV cohort)
Number of subjects: 495
Study 32081489 — intervention group
Group type: EXPERIMENTAL
Intervention: Proxima B (fellow eye intermediate AMD cohort)
Number of subjects: 495
Study 32081489 — intervention group
Group type: EXPERIMENTAL
Intervention: Proxima A (BCVA)
Number of subjects: 495
Study 32081489 — intervention group
Group type: EXPERIMENTAL
Intervention: Proxima B (fellow eye CNV cohort, BCVA)
Number of subjects: 495
Study 32081489 — intervention group
Group type: EXPERIMENTAL
Intervention: Proxima B (fellow eye intermediate AMD cohort, BCVA)
Number of subjects: 495
Study 32081489 — intervention group
Group type: EXPERIMENTAL
Intervention: Proxima A (LLVA)
Number of subjects: 495
Study 32081489 — intervention group
Group type: EXPERIMENTAL
Intervention: Proxima B (fellow eye CNV cohort, LLVA)
Number of subjects: 495
Study 32081489 — intervention group
Group type: EXPERIMENTAL
Intervention: Proxima B (fellow eye intermediate AMD cohort, LLVA)
Number of subjects: 495
Study 32081489 — intervention group
Group type: EXPERIMENTAL
Intervention: Proxima B (intermediate AMD cohort)
Number of subjects: 495
Study 35143365 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (10 Hz stimulation for 20 minutes, 1200 pulses per session for five consecutive days)
Number of subjects: 26
Study 35143365 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS (control)
Number of subjects: 26
Study 35143365 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 26
Study 34526086 — intervention group
Group type: COMPARATOR
Intervention: Placebo-controlled trials
Number of subjects: 0
Study 34526086 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label trials
Number of subjects: 0
Study 34526086 — intervention group
Group type: EXPERIMENTAL
Intervention: At-risk priority groups
Number of subjects: 0
Study 34526086 — intervention group
Group type: EXPERIMENTAL
Intervention: Blinded stepped-wedge cross-over design
Number of subjects: 0
Study 34526086 — intervention group
Group type: EXPERIMENTAL
Intervention: Blinded active-controlled stepped-wedge cross-over trial
Number of subjects: 0
Study 34526086 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised stepped-wedge community trials
Number of subjects: 0
Study 32285810 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication
Number of subjects: 75
Study 32285810 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in the 'Asthma School'
Number of subjects: 75
Study 32285810 — intervention group
Group type: COMPARATOR
Intervention: Basic therapy
Number of subjects: 75
Study 33921101 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive verbal suggestion
Number of subjects: 42
Study 33921101 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative verbal suggestion
Number of subjects: 42
Study 33921101 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral verbal suggestion
Number of subjects: 42
Study 33041038 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mL of a 1:1 fish to flaxseed oil supplement in colostrum
Number of subjects: 24
Study 33041038 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mL of a 1:1 fish to flaxseed oil supplement in colostrum
Number of subjects: 24
Study 33041038 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mL of a 1:1 fish to flaxseed oil supplement in colostrum
Number of subjects: 24
Study 33041038 — intervention group
Group type: COMPARATOR
Intervention: 0 mL of a 1:1 fish to flaxseed oil supplement in colostrum (control group)
Number of subjects: 24
Study 34635140 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable + Symptom Data Algo (Ava bracelet data + Daily Symptom Diary data)
Number of subjects: 20000
Study 34635140 — intervention group
Group type: COMPARATOR
Intervention: Symptom Only Algo (Daily Symptom Diary data alone)
Number of subjects: 20000
Study 32705829 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongdu Tiaoshen needling (electroacupuncture at Baihui (GV20), Shenting (GV24), Yintang (EX-HN3), bilateral Shenmen (HT7), and bilateral Sanyinjiao (SP6))
Number of subjects: 60
Study 32705829 — intervention group
Group type: COMPARATOR
Intervention: Superficial acupuncture (at Shousanli (LI10), Futu (ST32), and Feiyang (BL58))
Number of subjects: 60
Study 35273520 — intervention group
Group type: EXPERIMENTAL
Intervention: GATE
Number of subjects: 16
Study 32620131 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training (RAGT)
Number of subjects: 10
Study 32620131 — intervention group
Group type: COMPARATOR
Intervention: Non-assisted gait training (NAGT)
Number of subjects: 10
Study 34923371 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention Bias Modification (ABM)
Number of subjects: 84
Study 34923371 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 34923371 — intervention group
Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 84
Study 32881648 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume high-intensity interval training (HIIT)
Number of subjects: 99
Study 32881648 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity continuous training (MICT)
Number of subjects: 99
Study 33915381 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent management training (PMT)
Number of subjects: 42
Study 33915381 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 42
Study 33016505 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibroblast growth factor 23 (FGF23) concentrations
Number of subjects: 2309
Study 34259393 — intervention group
Group type: EXPERIMENTAL
Intervention: ART-40W
Number of subjects: 133
Study 34259393 — intervention group
Group type: COMPARATOR
Intervention: ART-Def
Number of subjects: 133
Study 34259393 — intervention group
Group type: COMPARATOR
Intervention: CHU
Number of subjects: 133
Study 34259393 — intervention group
Group type: EXPERIMENTAL
Intervention: CLWH
Number of subjects: 133
Study 33114566 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronized lipid‐based carotenoid supplement, Lumega‐Z (LM)
Number of subjects: 68
Study 33114566 — intervention group
Group type: EXPERIMENTAL
Intervention: PreserVision Age‐Related Eye Disease Study 2 (AREDS‐2) soft gel (PV)
Number of subjects: 68
Study 33114566 — intervention group
Group type: COMPARATOR
Intervention: Control group (ocular normal individuals)
Number of subjects: 68
Study 32088134 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal topography assessment of multifocal contact lenses (MCLs) centration
Number of subjects: 22
Study 32088134 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual assessments by 4 practitioners using 3 different algorithms
Number of subjects: 22
Study 32088134 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-class correlation coefficient among the 3 readings for each manual procedure
Number of subjects: 22
Study 34379236 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Intervention
Number of subjects: 199
Study 34379236 — intervention group
Group type: COMPARATOR
Intervention: Original Intervention
Number of subjects: 199
Study 32980253 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Behavioral Activation for Improving Social Connectedness
Number of subjects: 0
Study 32980253 — intervention group
Group type: COMPARATOR
Intervention: Friendly visit
Number of subjects: 0
Study 32677614 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin C (MMC) alone (0.1 mg/ml for 1 minute)
Number of subjects: 50
Study 32677614 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC) plus Ologen
Number of subjects: 50
Study 36089222 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% EGCG with ethanol wet-bonding for 60 s
Number of subjects: 0
Study 36089222 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% EGCG with ethanol wet-bonding for 60 s
Number of subjects: 0
Study 36089222 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% EGCG/ethanol solutions
Number of subjects: 0
Study 36089222 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% EGCG
Number of subjects: 0
Study 36089222 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% EGCG
Number of subjects: 0
Study 36089222 — intervention group
Group type: COMPARATOR
Intervention: Absolute ethanol wet-bonding for 60 s
Number of subjects: 0
Study 36089222 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study 36131172 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin rota-flush solution
Number of subjects: 200
Study 36131172 — intervention group
Group type: COMPARATOR
Intervention: Traditional rota-flush solution
Number of subjects: 200
Study 32946605 — intervention group
Group type: EXPERIMENTAL
Intervention: Stem cell transplantation
Number of subjects: 1552
Study 32946605 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 1552
Study 36482453 — intervention group
Group type: EXPERIMENTAL
Intervention: BEAR (Blended E‐health for children at eArly Risk)
Number of subjects: 88
Study 36482453 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual (CAU)
Number of subjects: 88
Study 33506496 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol plus dexmedetomidine
Number of subjects: 66
Study 33506496 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 66
Study 32717669 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart glasses
Number of subjects: 20
Study 32717669 — intervention group
Group type: COMPARATOR
Intervention: Smartphone
Number of subjects: 20
Study 32717669 — intervention group
Group type: COMPARATOR
Intervention: Paper-based system
Number of subjects: 20
Study 36036925 — intervention group
Group type: EXPERIMENTAL
Intervention: Vamorolone, 6 mg/kg per day
Number of subjects: 133
Study 36036925 — intervention group
Group type: EXPERIMENTAL
Intervention: Vamorolone, 2 mg/kg per day
Number of subjects: 133
Study 36036925 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone, 0.75 mg/kg per day
Number of subjects: 133
Study 36036925 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 133
Study 36036925 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups (including vamorolone and prednisone)
Number of subjects: 133
Study 33714372 — intervention group
Group type: EXPERIMENTAL
Intervention: EBRT (External Beam Radiotherapy)
Number of subjects: 199
Study 33714372 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 199
Study 33174590 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated humidified high-flow nasal cannula (HHHFNC)
Number of subjects: 128
Study 33174590 — intervention group
Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure (nCPAP)
Number of subjects: 128
Study 32684473 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate milk replacer (0.66 kg DM) with gradual weaning (21-d step-down)
Number of subjects: 50
Study 32684473 — intervention group
Group type: EXPERIMENTAL
Intervention: High milk replacer (up to 1.1 kg DM) with abrupt weaning (7-d step-down)
Number of subjects: 50
Study 32684473 — intervention group
Group type: EXPERIMENTAL
Intervention: High milk replacer (up to 1.1 kg DM) with gradual weaning (21-d step-down)
Number of subjects: 50
Study 32684473 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate milk replacer (0.66 kg DM) with abrupt weaning (7-d step-down)
Number of subjects: 50
Study 35831153 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab 140 mg every 2 weeks combined with atorvastatin 40 mg/day and ezetimibe 10 mg/day
Number of subjects: 136
Study 35831153 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 40 mg/day and ezetimibe 10 mg/day (Control)
Number of subjects: 136
Study 34076400 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene 0.045% lotion
Number of subjects: 1542
Study 34076400 — intervention group
Group type: COMPARATOR
Intervention: Vehicle lotion
Number of subjects: 1542
Study 32135208 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks (adults)
Number of subjects: 1505
Study 32135208 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 200 mg or 300 mg every 2 weeks (adolescents)
Number of subjects: 1505
Study 32135208 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 1505
Study 32135208 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1505
Study 35507726 — intervention group
Group type: EXPERIMENTAL
Intervention: Actual table tennis training
Number of subjects: 48
Study 35507726 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated table tennis (exergame)
Number of subjects: 48
Study 35507726 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional training)
Number of subjects: 48
Study 34823494 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity exercise with self-regulatory behaviour change techniques (BCTs)
Number of subjects: 577
Study 34823494 — intervention group
Group type: COMPARATOR
Intervention: High intensity exercise without self-regulatory behaviour change techniques (BCTs)
Number of subjects: 577
Study 34823494 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-to-moderate intensity exercise with self-regulatory behaviour change techniques (BCTs)
Number of subjects: 577
Study 34823494 — intervention group
Group type: COMPARATOR
Intervention: Low-to-moderate intensity exercise without self-regulatory behaviour change techniques (BCTs)
Number of subjects: 577
Study 34823494 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher health-related quality-of-life (HRQoL)
Number of subjects: 577
Study 34823494 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher exercise motivation
Number of subjects: 577
Study 34823494 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher exercise expectations
Number of subjects: 577
Study 34823494 — intervention group
Group type: EXPERIMENTAL
Intervention: History of tobacco use
Number of subjects: 577
Study 34823494 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater BMI increases during the exercise intervention
Number of subjects: 577
Study 36398123 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid-based cytology (LBC)
Number of subjects: 3677
Study 36398123 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual inspection with acetic acid and Lugol's iodine (VIA/VILI)
Number of subjects: 3677
Study 36398123 — intervention group
Group type: COMPARATOR
Intervention: Direct COLP for HPV16/18+
Number of subjects: 3677
Study 36398123 — intervention group
Group type: COMPARATOR
Intervention: Direct COLP for other hrHPV subtypes+
Number of subjects: 3677
Study 36398123 — intervention group
Group type: EXPERIMENTAL
Intervention: LBC triage for other hrHPV subtypes+
Number of subjects: 3677
Study 33729175 — intervention group
Group type: EXPERIMENTAL
Intervention: GSV sparing
Number of subjects: 36
Study 33729175 — intervention group
Group type: COMPARATOR
Intervention: GSV stripping
Number of subjects: 36
Study 34215610 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation strategy employing peer-led educational outreach, a clinical support tool, and peer support network to implement a TB treatment adherence intervention.
Number of subjects: 88
Study 32194058 — intervention group
Group type: EXPERIMENTAL
Intervention: HAT therapy (hydrocortisone, ascorbic acid, thiamine)
Number of subjects: 137
Study 32194058 — intervention group
Group type: COMPARATOR
Intervention: Comparator group (placebo)
Number of subjects: 137
Study 35078522 — intervention group
Group type: EXPERIMENTAL
Intervention: Unplugged program (Yo Sé Lo Que Quiero)
Number of subjects: 8400
Study 35078522 — intervention group
Group type: COMPARATOR
Intervention: Standard school preventive curricula
Number of subjects: 8400
Study 33982452 — intervention group
Group type: EXPERIMENTAL
Intervention: TLPLDC vaccine
Number of subjects: 0
Study 33982452 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32474584 — intervention group
Group type: EXPERIMENTAL
Intervention: Potentially inappropriate medication (PIM) use
Number of subjects: 448